PTK2 and neoplasm: In recent years, more inhibitors like BI 853,520 have been studied, which is a highly selective FAK inhibitor that has shown good results in mouse models for reducing tumor growth in adenocarcinoma, but it still has issues with long-term effects in humans due to poor bioavailability and clearance rates12.